Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin Ketorolac
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of particulate matter - Glass like particles.
- Products
-
- Dexamethasone Moxifloxacin Ketorolac
- Company
- Imprimis NJOF, LLC
- Where it was sold
-
U.S Nationwide
Nationwide
- Units affected
- 596 boxes of 11,920 pre-filled syringes
- About this recall
- Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.